98%
921
2 minutes
20
Multimorbidity, the coexistence of two or more chronic conditions, presents a growing global challenge, particularly in low- and middle-income countries such as Southeast Asia. This trend necessitates the development of sustainable integrated care models to prevent and manage multimorbidity effectively. However, progress in this area has been hampered, especially in underdeveloped regions, by various barriers, including the epidemiology of multimorbidity, how to get different specialists and doctors to work together most availably and manage the multiple medication issues and how to develop cost-effective approaches to reduce the health burden of multimorbidity. Preventive measures in Southeast Asia, which could tackle multiple components which commonly comprise multimorbidity, include enhancing health literacy and health promotion through school- and community-based educational activities, primary healthcare and related policies on employing taxes on tobacco, alcohol and sugary beverages. The social determinants of health-encompassing poverty and low education may also influence research on multimorbidity. Moreover, stakeholder engagements involving national governments, World Health Organization (WHO) and Association of Southeast Asian Nations (ASEAN) are crucial. Management strategies focus on integrated care models, including patient-centred primary healthcare, digital healthcare technologies, and medication management to control polypharmacy. Although research on multimorbidity in Southeast Asia is increasing, translating findings into practical measures was limited. Future efforts should prioritize evidence-based approaches to prevent and manage multimorbidity effectively, addressing challenges like health system focusing on single chronic disease treatment independently, resource limitations, healthcare provider shortages and individual adherence issues. These ways promise to enhance the quality of life and health outcomes in this region.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12039666 | PMC |
http://dx.doi.org/10.1002/puh2.218 | DOI Listing |
JMIR Res Protoc
September 2025
Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
Background: Various media are used to enhance public understanding about diseases. While mobile health apps are widely used, there is little proof for using such apps to raise awareness of skin diseases.
Objective: We intend to develop an app, called DEDIKASI-app, to raise awareness of skin diseases, including leprosy.
Health Promot Int
September 2025
Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, 02 Duong Quang Trung Street, Hoa Hung Ward, Ho Chi Minh City 700000, Vietnam.
Health literacy (HL) is a fundamental factor in raising health awareness and self-management, especially in contexts with increasingly complicated health systems. Its accurate and culturally appropriate measurement is necessary to support effective medical interventions. Accordingly, we translated the Health Literacy Questionnaire (HLQ) into Vietnamese and analysed its psychometric properties on the basis of data derived from respondents who completed the translated instrument.
View Article and Find Full Text PDFLancet Reg Health Southeast Asia
October 2025
Department of Pharmacy Administration, School of Pharmacy, Xi'an Jiaotong University, Xi'an, China.
Background: Poverty is a potential contributor to antibiotic resistance; however, the previous studies have not adequately addressed the role of poverty in shaping antibiotic resistance through social inequalities. Considering this, the current study evaluated the role of multi-dimensional poverty in antibiotic resistance.
Methods: A mixed-method study was conducted in three provinces of Pakistan using multistage sampling to recruit physician-confirmed urinary tract infection (UTI) patients from public laboratories.
Oncol Res
September 2025
Division of Hematopoiesis, Joint Research Center for Human Retrovirus Infection & Graduate School of Medical Sciences, Kumamoto University 2-2-1 Honjo, Chuo-ku, Kumamoto, 860-0811, Japan.
Cholangiocarcinoma (CCA) is a fatal bile duct malignancy. CCA is intrinsically resistant to standard chemotherapy, responds poorly to it, and has a poor prognosis. Effective treatments for cholangiocarcinoma remain elusive, and a breakthrough in CCA treatment is still awaited.
View Article and Find Full Text PDFForensic Sci Int Synerg
December 2025
DNA Analysis Laboratory, Natural Sciences Research Institute, University of the Philippines Diliman, Quezon City 1101 Philippines.
Massively parallel sequencing (MPS) has caused a paradigm shift in forensic DNA analysis by enabling simultaneous examination of multiple genetic markers with higher resolution. Despite its growing importance, adoption in the 11 Southeast Asian countries remains limited. This paper reviews MPS implementation in forensic DNA laboratories across the region and discusses key adoption challenges.
View Article and Find Full Text PDF